Corrina Roman Kreuze serves as Director, Quality at Hemab. She has 30 years of experience in the pharmaceutical, biotech and gene therapy industry. She started her career as a Medical Technologist in Hematology. Over the course of her career, she transitioned from hospital laboratory into industry, and has worked on enzyme replacement therapeutics (Replagal®) at Transkaryotic Therapies , viral cancer therapeutics at BioVex, small molecule therapeutics including Cubicin®, Cubicin RF®,at Cubist, and the Gardasil®9 vaccine at Merck. She most recently served as Head of Quality at Freeline Therapeutics where she worked on gene therapy treatments for Hemophilia A, Fabry’s Disease and Gaucher’s Disease. Corrina earned a BSc in Medical Laboratory Science from the University of New Hampshire.